All In Biotech

Drug Trial Radar · NCT05025605

Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder

A Randomized, Double-blind, Placebo-controlled Study to Determine Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder

Last checked: Nov 20, 2026Latest source record: Aug 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 140 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

140

Planned (sponsor's estimate)

Start

Aug 27, 2021

Primary completion

Jul 31, 2027

Study completion Dec 31, 2027

Sponsor

Lead sponsor
BioXcel Therapeutics IncIndustry
Sponsor type
Industry
Collaborators
ProPharma Group
First posted
Aug 27, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 10 years, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a study of the efficacy and safety of BXCL501 in children and adolescents with acute agitation and either bipolar disorder or schizophrenia.

Conditions

  • Schizophrenia
  • Schizo-Affective Disorder
  • Schizophreniform; Schizophrenic
  • Bipolar Disorder I
  • Bipolar Disorder II

Interventions

  • BXCL501 80 MicrogramsDrug

    Sublingual film containing 80 Micrograms BXCL501

  • Placebo FilmDrug

    Matching Sublingual Placebo film

  • BXCL501 120 MicrogramsDrug

    Sublingual film containing 120 Micrograms BXCL501

  • BXCL501 60 MicrogramsDrug

    Sublingual film containing 60 Micrograms BXCL501 Europe Only

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Absolute change from baseline in the Positive and Negative Syndrome Scale - Excited Component (PEC) total scoreTime frame: 120 minutes - Group one only

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • BioXcel Clinical Research Site

    Anaheim, California · Recruiting

  • Bioxcel Clinical Research Site

    Hialeah, Florida · Recruiting

  • BioXcel Clinical Research Site

    Atlanta, Georgia · Completed

  • Bioxcel Clinical Research Site

    Decatur, Georgia · Recruiting

  • BioXcel Clinical Research Site

    DeSoto, Texas · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.